Vectopia, a University of Geneva spin-off, develops a new production method for lentiviral vectors used in gene therapy. The project receives a CHF 50,000 FIF Grant to move towards market.
- Announced on
- Round
- Grant
- Amount
- CHF 50,000
- Location
- Geneva
- Sector
- Biotech & life sciences
Investors
- FIF Genève lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic